QA: Johnson Johnson in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2019_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 46,033,000,000
1 IntangibleAssetsNetIncludingGoodwill 78,064,000,000
2 PropertyPlantAndEquipmentNet 17,035,000,000
3 remainder_Assets 11,822,000,000
4 LiabilitiesCurrent 31,230,000,000
5 LiabilitiesNoncurrent 36,273,000,000
6 remainder_Liabilities 25,699,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,522,122,527
9 ResearchAndDevelopmentExpense 10,777,746,488
10 remainder_Expenses 34,569,999,863
11 remainder_Revenues 81,607,183,029
12 remainder_NetIncome -685,067,882
13 remainder_ComprehensiveNetIncome -1,397,790,440
  yvar yval
0 Assets 152,954,000,000
1 Liabilities 93,202,000,000
2 Expenses 67,869,868,878
3 Revenues 81,607,183,029
4 StockholdersEquity 59,752,000,000
5 NetIncome 13,052,246,269
6 ComprehensiveNetIncome 12,353,351,049
7 BaseVar 198,857,955,114
8 EconomicCapitalRatiobeforeLimitedLiability 1.16
9 EconomicCapitalRatio 2.43

Edgar->Model Mapping

Feature Distribution

Change over Time